January/February 2010, Vol 3, No 1
Orphan Drug Pricing and Payer Management in the United States: Are We Approaching the Tipping Point?
Orphan Drugs: The Potential Impact of Generic Biologics
Diabetes Management Strategies: More Money Does Not Equal Better Care
Joann Dominguez, MD, Loida Nguyen, PharmD, Nageshwara Gullapalli, MD, Quang T. Nguyen, DO, FACE, FTOS
Hypertension Management: Implications to Patients, Providers, and Payers
Results 1 - 7 of 7